UNSPSC 51384201: Fenoprofen

This classification denotes a cyclooxygenase inhibitor with the molecular formula C15H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RA33EAC7KY, chemically known as hydratropic acid, m-phenoxy-, (+-)- but generally known as fenoprofen, which bears US NIH Compound Identifier 3342. European Medicines Agency schedules Fenoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07578MIG.

UNSPSC 51384201 Fenoprofen (Commodity) does not align with the recent state and local procurement activity tagged under this code. The three most recent opportunities—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's RFI on direct-to-manufacturer prescription programs, and Minnesota's MMCAP RFP for generic multi-source pharmaceuticals and OTC products—concern pharmaceutical supply, distribution channels, and over-the-counter inventory, none of which involve fenoprofen specifically or match the scope of a single nonsteroidal anti-inflammatory drug product. State and local health departments, county public health programs, and cooperative purchasing alliances are the issuing bodies active under this code designation, but the mismatch between the code name and the actual procurement scope suggests either a classification error in how opportunities are tagged or a very limited recent market for fenoprofen procurement in the jurisdictions tracked here.

No recent solicitation specifically names fenoprofen or seeks procurement of this pharmaceutical product as a primary deliverable. The code shows little relevant recent activity, and the three opportunities presently tagged to it address broader pharmaceutical sourcing, supply-chain partnerships, and multi-product inventory management rather than individual active pharmaceutical ingredients or finished formulations targeting a named drug product. Business development professionals pursuing this code should verify whether state and local procurement offices are actively seeking fenoprofen through separate channels or whether activity under this designation has shifted to broader pharmaceutical-supply categories.